Efferent Labs Talks about Delivering Real-time In Vivo Data Acquisition
In this first of three segments, Sharon Spielman, VSD's editor in chief, speaks with Efferent Labs' CEO Bill Rader about the company's CytoComm platform.
This edition of "Visions: A Machine Vision and Automations Solutions Podcast" is the first of three interview segments by VSD's Editor in Chief Sharon Spielman of Bill Rader and Alex Drew, CEO andCOO, respectively, of Efferent Labs. The medical/life sciences technology company has developed a platform that is set to revolutionize the development of new treatments for chronic and deadly diseases by utilizing live cellular data acquisition.
By integrating advanced biosensors, target cells, smart materials, and AI-powered analytics, the CytoComm platform is able to deliver real-time in vivo data that reveals cellular responses as they happen.
Visions: A Machine Vision and Automation Solutions Podcast, is the podcast for engineers, designers, integrators, and end users who want to keep an informed eye on the imaging and machine vision industry. Every second and fourth Tuesday we will explore the latest in imaging trends, developments and solutions. Here you will find interesting, useful insights and observations from expert interviews, solo episodes, even the occasional panel discussion, all of which aim to expand your knowledge on imaging and machine vision.
Be sure to subscribe to Visions: A Machine Vision and Automation Solutions podcast on podbean, or wherever you find quality podcasts.
VSD Senior Editor Jim Tatum has more than 25 years experience in print and digital journalism, covering business/industry/economic development issues, regional and local government/regulatory issues, and more. In 2019, he transitioned from newspapers to business media full time, joining VSD in 2023.
